Turn profit-patient into patient-profit
Transforming your profit-patient model into a patient-profit system is one of the biggest shake-ups in pharma's history.
Many major brands are already in the process of creating and developing a new patient-centric approach, and introducing measures to reward staff against patient-oriented metrics.
What was once an ‘if?’ has become a ‘when and how?’. But changing an engrained mind-set requires a collaborative effort; the more companies that encourage–and in some cases enforce–patient-centricity, the more widespread the buy-in will be.
‘Profit’ is still a valid talking point – it hasn’t become a dirty word. What has changed is that it is now being seen as a natural by-product of putting patients first.
Now that patients are being almost universally regarded as pivotal to the sustained growth of pharma, the question turns back to: how will an inverted model still provide profit for pharma and key stakeholders?
The conference aims to help pharma stakeholders share views, and examine ways to put patients at the centre of evolving pharma business models, without damaging profits. Putting patients first needs to be attractive on both the humanistic and fiscal levels in order for patient centricity to thrive.
It won’t happen overnight.
New strategies need to be implemented to reshape business structures and positively influence internal thinking. The message that patients are pharma’s number one business priority needs to filter down from C-level to the root system of every pharma-related business.